Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways

Ana Paula Morelli(Universidade Estadual de Campinas (UNICAMP)), Fernando Moreira Simabuco(Universidade Estadual de Campinas (UNICAMP))

International Journal of Oncology

April 8, 2021

10.3892/ijo.2021.5208

Cited by 26

Related Papers

Modulation of hypothalamic S6K1 and S6K2 alters feeding behavior and systemic glucose metabolism

|Journal of Endocrinology|2019|13

Caracterização de alvos moleculares envolvidos na resistência quimioterápica e no metabolismo tumoral de células de câncer de pulmão

|Unknown|2022|0

Partial Proliferating Cell Nuclear Antigen Functional Knockout Impairs Cisplatin Resistance and Clonogenic Potential in Lung Adenocarcinoma Cells

|DNA|2025|0